Kruthi Suvarna

1 Introduction Hepatocellular carcinoma (HCC), a prevalent form of cancer globally, ranks third in mortality rates, contributing to over 780,000 deaths in 2018 as per the Global Cancer Statistics (Bray et al., 2018). Primary liver cancer encapsulates intrahepatic cholangiocarcinoma (ICC), HCC, among other types, with HCC constituting more than 80% of all liver cancer cases. Notably, HCC incidence has witnessed a surge in Europe and South America (Chu et al., 2019).

Sonu Kumar1 Neeti Nadda1 Afnan Quadri1 Rahul Kumar2 Shashi Paul3 Pranay Tanwar2 Shivanand Gamanagatti3 Nihar Ranjan Dash4 Anoop Saraya1 Shalimar1 Baibaswata Nayak1* 1Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India 2Laboratory Oncology Unit (BRA-IRCH), All India Institute of Medical Sciences, New Delhi, India 3Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India 4Gastrointestinal Surgery, All India Institute of Medical Sciences,...

Kruthi Suvarna‡,§1, Kaori Honda‡,¶, Makoto Muroi¶, Yasumitsu Kondoh¶, Hiroyuki Osada¶,‖ and Nobumoto Watanabe‡,§,‖2 From the ‡Bio-Active Compounds Discovery Research Unit, ¶Chemical Biology Research Group, and ‖RIKEN–Max Planck Joint Research Division, RIKEN Center for Sustainable Resource Science, Saitama 351-0198, Japan and the §Tokyo Medical Dental University, Yushima, Tokyo 113-8510, Japan ↵2 To whom correspondence should be addressed: Bioprobe Application Research Unit, RIKEN-Max Planck...